ResMed Newsroom

Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA) and Resmed (RMD)

TipRanksSep 28 01:32

Baird Maintains ResMed(RMD.US) With Buy Rating, Maintains Target Price $280

Futu NewsSep 28 01:32

BofA Securities Maintains ResMed(RMD.US) With Buy Rating, Announces Target Price $270

Futu NewsSep 26 17:33

Resmed Poised for Growth Amid Rising OSA Diagnosis and Market Opportunity: Buy Rating Reaffirmed With Increased Price Objective

TipRanksSep 26 17:18

ResMed Analyst Ratings

BenzingaSep 24 18:27

Baird Initiates Coverage On ResMed With Outperform Rating, Announces Price Target of $280

BenzingaSep 24 18:27

Baird Initiates ResMed(RMD.US) With Buy Rating, Announces Target Price $280

Futu NewsSep 24 04:31

Needham Maintains ResMed(RMD.US) With Hold Rating

Futu NewsSep 18 18:31

Resmed (RMD) Receives a Hold From Needham

TipRanksSep 18 18:19

ResMed Analyst Ratings

BenzingaSep 18 17:52

Wolfe Research Downgrades ResMed(RMD.US) to Sell Rating, Announces Target Price $180

Futu NewsSep 18 17:31

Wolfe Research Downgrades ResMed to Underperform From Peer Perform, Price Target Is $180

MT NewswiresSep 18 17:19

ResMed Faces Market Disruption and Limited Growth: A Sell Rating Analysis

TipRanksSep 18 16:53

Analysts Offer Insights on Healthcare Companies: Y-Mabs Therapeutics (YMAB), Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (AU:RMD) and Bayer (GB:0P6S)

TipRanksSep 11 17:04

ResMed Price Target Maintained With a $236.00/Share by Needham

Dow JonesSep 4 18:09

Needham Downgrades ResMed(RMD.US) to Hold Rating

Futu NewsSep 4 17:31

Resmed (RMD) Was Downgraded to a Hold Rating at Needham

TipRanksSep 4 17:17

William Blair Initiates ResMed(RMD.US) With Buy Rating

Futu NewsAug 27 23:31

Morgans Keeps Their Buy Rating on Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD)

TipRanksAug 5 08:07

RBC Capital Maintains Sector Perform on ResMed, Raises Price Target to $206

BenzingaAug 3 04:47